Sigyn Therapeutics annual revenue
2014
2015
2018
2019
Sigyn Therapeutics reported $143,322 in revenue for fiscal 2019, an increase of 405.58% from the previous fiscal year.
View full Sigyn Therapeutics company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | $143,322 | $114,974 | +405.58% |
| 2018 | 2018-12-31 | $28,348 | −$859 | −2.94% |
| 2015 | 2015-12-31 | $29,207 | −$13,947 | −32.32% |
| 2014 | 2014-12-31 | $43,154 | — | — |
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Sigyn Therapeutics filings at SEC.gov ↗